Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Context Therapeutics Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/31/2023 4 Kantoff Philip W. (Director) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $0.87, valued at $21.8k
05/31/2023 4 West Linda (Director) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $0.87, valued at $21.8k
05/31/2023 4 Stacey Jennifer Evans (Director) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $0.87, valued at $21.8k
05/31/2023 4 BERMAN RICHARD J (Director) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 50,000 options to buy @ $0.87, valued at $43.5k
02/21/2023 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 5,823 shares @ $0.8415, valued at $4.9k
02/14/2023 4 Levit Alex C. (Chief Legal Officer, Corp. Sec) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 151,505 options to buy @ $0.8407, valued at $127.4k
02/14/2023 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 287,544 options to buy @ $0.8407, valued at $241.7k
02/14/2023 4 Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 158,001 options to buy @ $0.8407, valued at $132.8k
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/06/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/30/2023 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 7,027 shares @ $0.6974, valued at $4.9k
01/23/2023 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 6,839 shares @ $0.7166, valued at $4.9k
01/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 20,000 shares @ $0.7398, valued at $14.8k
12/12/2022 4 Levit Alex C. (Chief Legal Officer, Corp. Sec) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 6,000 shares @ $0.8491, valued at $5.1k
08/22/2022 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 13,000 shares @ $1.8511, valued at $24.1k
08/17/2022 4 Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 15,000 shares @ $1.8, valued at $27k
08/17/2022 4 Sahmoud Tarek (Chief Medical Officer) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 10,000 shares @ $1.95, valued at $19.5k
08/12/2022 4 Sahmoud Tarek (Chief Medical Officer) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 25,000 options to buy @ $1.96, valued at $49k
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2022 4 Levit Alex C. (Chief Legal Officer, Corp. Sec) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 107,870 options to buy @ $1.79, valued at $193.1k
02/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2022 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 254,300 options to buy @ $1.79, valued at $455.2k
02/17/2022 4 Dick Evan G. (Former Section 16 officer) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 29,223 options to buy @ $2.05, valued at $59.9k
02/17/2022 4 Rencher William F. (Former Section 16 officer) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 8,000 options to buy @ $2.05, valued at $16.4k
12/20/2021 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 13,000 shares @ $3.2192, valued at $41.8k
11/01/2021 4 Minai-Azary Jennifer Lynn (CFO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Granted 52,753 options to buy @ $5.59, valued at $294.9k
10/25/2021 4 Levit Alex C. (Chief Legal Officer, Corp. Sec) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 3,000 shares @ $5, valued at $15k
10/25/2021 4 Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.
Txns: Bought 10,000 shares @ $5, valued at $50k
Converted 210,722 shares @ $0
Converted 586,476 shares @ $0
Exercised (out-of-the-money) 52,680 warrants @ $7.14, valued at $376.1k
Converted 210,722 preferred shares @ $0
Converted 586,476 options to buy @ $0
10/25/2021 4 Dick Evan G. (SVP of R&D) has filed a Form 4 on Context Therapeutics Inc.
Txns: Converted 26,587 shares @ $0
Converted 26,587 options to buy @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy